Company Profiles

driven by the PitchBook Platform

Xeris Pharmaceuticals

Description

Developer of a glucagon rescue pen for emergency treatment of severe hypoglycemia. The company develops injectable drugs based on its non-aqueous XeriJect and XeriSol formulation and delivery platforms.

2005

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$71M

Latest Deal Amount

$90.8M

Total Amount Raised

Description

Developer of a glucagon rescue pen for emergency treatment of severe hypoglycemia. The company develops injectable drugs based on its non-aqueous XeriJect and XeriSol formulation and delivery platforms.

Website:

www.xerispharma.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

3208 Red River Street Suite 300 Austin, TX 78705United States +1 (512) 498-2670
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Xeris Pharmaceuticals's full profile, request a free trial.

    Xeris Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Xeris Pharmaceuticals Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Xeris Pharmaceuticals Investors (13)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Annex VenturesVenture CapitalMinority000 0000000 0000
    Asahi Kasei Corporate Venture CapitalCorporate Venture CapitalMinority000 0000000 0000
    Austin Technology IncubatorAccelerator/Incubator000 0000000 0000
    Bay City CapitalVenture CapitalMinority000 0000000 0000
    Central Texas Angel NetworkAngel GroupMinority000 0000000 0000
    Annex Ventures Venture Capital
    Asahi Kasei Corporate Venture Capital Corporate Venture Capital
    Austin Technology Incubator Accelerator/Incubator
    Bay City Capital Venture Capital
    Central Texas Angel Network Angel Group

    Xeris Pharmaceuticals Executive Team (5)

    NameTitleBoard
    Seat
    Contact
    Info
    Paul EdickChief Executive Officer, Board Member & President
    Yash Sabharwal Ph.DChief Operating Officer & Chief Financial Officer
    Phillip JohnsonChief Financial Officer
    Steven Prestrelski Ph.DChief Scientific Officer, Co-Founder & Director
    John Kinzell Ph.DExecutive Vice President, Corporate Development, Director & Co-Founder
    Paul Edick Chief Executive Officer, Board Member & President
    Yash Sabharwal Ph.D Chief Operating Officer & Chief Financial Officer
    Phillip Johnson Chief Financial Officer
    Steven Prestrelski Ph.D Chief Scientific Officer, Co-Founder & Director
    John Kinzell Ph.D Executive Vice President, Corporate Development, Director & Co-Founder

    Xeris Pharmaceuticals Board Members (3)

    NameRepresentingRoleSinceContact
    Info
    Navneet Puri Ph.DSelfBoard Member000 0000
    Robert FaulknerRedmile GroupManaging Director000 0000
    Shane BrisbinSelfDirector000 0000
    Navneet Puri Ph.D Board Member Self
    Robert Faulkner Managing Director Redmile Group
    Shane Brisbin Director Self
    Request full access to PitchBook